Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Medtronic
Colorcon
Queensland Health
Cipla
Dow
AstraZeneca
Johnson and Johnson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084573

« Back to Dashboard

NDA 084573 describes DERMACORT, which is a drug marketed by Monarch Pharms and Solvay and is included in three NDAs. Additional details are available on the DERMACORT profile page.

The generic ingredient in DERMACORT is hydrocortisone. There are sixty-four drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
Summary for 084573
Tradename:DERMACORT
Applicant:Solvay
Ingredient:hydrocortisone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084573

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:LOTION;TOPICALStrength0.5%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
US Department of Justice
Cantor Fitzgerald
US Army
Teva
Daiichi Sankyo
Julphar
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.